Cell line HT29-16E

Taxonomy

• Homo sapiens (Human)

Protein

• Unspecified mucin / Homo sapiens    

Source

• Colonic Mucosa (UBERON_0000317)   HT29-16E (CVCL_C763)  

Reported structure

• O-Linked / Core 1 / NeuAc(a2-3)Gal(b1-3)GalNAc
• O-Linked / Core 1 / NeuAc(a2-3)Gal(b1-3)[NeuAc(a2-6)]GalNAc
• O-Linked / Core 1 / NeuAc(a2-3)Gal(b1-3)GlcNAc(b1-3)Gal(b1-3)GalNAc
• O-Linked / Core 2 / Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
• O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[Gal(b1-3)]GalNAc
• O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
• O-Linked / Core 2 / HSO3(-6)[NeuAc(a2-3)]Gal(b1-4)GlcNAc(b1-6)[NeuAc(a2-3)Gal(b1-3)]GalNAc
• O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)[HSO3(-6)[NeuAc(a2-3)]Gal(b1-3)]GalNAc
• O-Linked / Core 2 / NeuAc(a2-3)Gal(b1-3)GlcNAc(b1-3)Gal(b1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]GalNAc
• O-Linked / Core 2 / HSO3(-6)[NeuAc(a2-3)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]GalNAc
• O-Linked / Core 4 / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-3)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]GalNAc
• O-Linked / Core 4 / NeuAc(a2-3)Gal(b1-?)GlcNAc(b1-3)[NeuAc(a2-3)Gal(b1-?)GlcNAc(b1-6)]GalNAc

Composition

• Hex:1 HexNAc:1 NeuAc:1 (avg mass : 674.6106 )
• Hex:1 HexNAc:1 NeuAc:2 (avg mass : 965.8685 )
• Hex:2 HexNAc:2 NeuAc:1 (avg mass : 1039.948 )
• Hex:2 HexNAc:2 NeuAc:2 (avg mass : 1331.2059 )
• Hex:2 HexNAc:2 NeuAc:2 Su:1 (avg mass : 1411.2701 )
• Hex:2 HexNAc:3 NeuAc:2 (avg mass : 1534.4009 )
• Hex:3 HexNAc:3 NeuAc:2 (avg mass : 1696.5433 )
• Hex:3 HexNAc:3 NeuAc:2 Su:1 (avg mass : 1776.6075 )

Disease

• Adenocarcinoma (DOID:299)

Reference

• Oligosaccharide structures of mucins secreted by the human colonic cancer cell line CL.16E. (1992 - Capon C, Laboisse C, Wieruszeski J, Maoret J, Augeron C, Fournet B) / Status : Reviewed

Reported glycosite

• Unspecified mucin / Homo sapiens
  •        Undefined site

Mass spectrometry observed peptide